Results:
Supplementary cells were exposed to LPS (100 μg/ml) or pretreated with recombinant human kallistatin at indicated doses for 1 h and then exposed to LPS for another 24 h.
Western blot analysis was used to determine the expression of TLR4; β-actin was used as an internal control. Results are representative of three independent experiments.
Histogram shows the relative band intensity of western blot from three independent experiments. Data are shown as the mean ± SEM and were analyzed by one-way ANOVA with Bonferroni's post hoc test. *P < 0.01.
